Cargando…

A cost‐effectiveness threshold based on the marginal returns of cardiovascular hospital spending

Traditionally, threshold levels of cost‐effectiveness have been derived from willingness‐to‐pay studies, indicating the consumption value of health (v‐thresholds). However, it has been argued that v‐thresholds need to be supplemented by so‐called k‐thresholds, which are based on the marginal returns...

Descripción completa

Detalles Bibliográficos
Autores principales: van Baal, Pieter, Perry‐Duxbury, Meg, Bakx, Pieter, Versteegh, Matthijs, van Doorslaer, Eddy, Brouwer, Werner
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585934/
https://www.ncbi.nlm.nih.gov/pubmed/30273967
http://dx.doi.org/10.1002/hec.3831
_version_ 1783428807705755648
author van Baal, Pieter
Perry‐Duxbury, Meg
Bakx, Pieter
Versteegh, Matthijs
van Doorslaer, Eddy
Brouwer, Werner
author_facet van Baal, Pieter
Perry‐Duxbury, Meg
Bakx, Pieter
Versteegh, Matthijs
van Doorslaer, Eddy
Brouwer, Werner
author_sort van Baal, Pieter
collection PubMed
description Traditionally, threshold levels of cost‐effectiveness have been derived from willingness‐to‐pay studies, indicating the consumption value of health (v‐thresholds). However, it has been argued that v‐thresholds need to be supplemented by so‐called k‐thresholds, which are based on the marginal returns to health care. The objective of this research is to estimate a k‐threshold based on the marginal returns to cardiovascular disease (CVD) hospital care in the Netherlands. To estimate a k‐threshold for hospital care on CVD, we proceed in two steps: First, we estimate the impact of hospital spending on mortality using a Bayesian regression modelling framework, using data on CVD mortality and CVD hospital spending by age and gender for the period 1994–2010. Second, we use life tables in combination with quality of life data to convert these estimates into a k‐threshold expressed in euros per quality‐adjusted life year gained. Our base case estimate resulted in an estimate of 41,000 per quality‐adjusted life year gained. In our sensitivity analyses, we illustrated how the incorporation of prior evidence into the estimation pushes estimates downwards. We conclude that our base case estimate of the k‐threshold may serve as a benchmark value for decision making in the Netherlands as well as for future research regarding k‐thresholds.
format Online
Article
Text
id pubmed-6585934
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-65859342019-06-27 A cost‐effectiveness threshold based on the marginal returns of cardiovascular hospital spending van Baal, Pieter Perry‐Duxbury, Meg Bakx, Pieter Versteegh, Matthijs van Doorslaer, Eddy Brouwer, Werner Health Econ Research Articles Traditionally, threshold levels of cost‐effectiveness have been derived from willingness‐to‐pay studies, indicating the consumption value of health (v‐thresholds). However, it has been argued that v‐thresholds need to be supplemented by so‐called k‐thresholds, which are based on the marginal returns to health care. The objective of this research is to estimate a k‐threshold based on the marginal returns to cardiovascular disease (CVD) hospital care in the Netherlands. To estimate a k‐threshold for hospital care on CVD, we proceed in two steps: First, we estimate the impact of hospital spending on mortality using a Bayesian regression modelling framework, using data on CVD mortality and CVD hospital spending by age and gender for the period 1994–2010. Second, we use life tables in combination with quality of life data to convert these estimates into a k‐threshold expressed in euros per quality‐adjusted life year gained. Our base case estimate resulted in an estimate of 41,000 per quality‐adjusted life year gained. In our sensitivity analyses, we illustrated how the incorporation of prior evidence into the estimation pushes estimates downwards. We conclude that our base case estimate of the k‐threshold may serve as a benchmark value for decision making in the Netherlands as well as for future research regarding k‐thresholds. John Wiley and Sons Inc. 2018-10-01 2019-01 /pmc/articles/PMC6585934/ /pubmed/30273967 http://dx.doi.org/10.1002/hec.3831 Text en © 2018 The Authors Health Economics Published by John Wiley & Sons, Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
van Baal, Pieter
Perry‐Duxbury, Meg
Bakx, Pieter
Versteegh, Matthijs
van Doorslaer, Eddy
Brouwer, Werner
A cost‐effectiveness threshold based on the marginal returns of cardiovascular hospital spending
title A cost‐effectiveness threshold based on the marginal returns of cardiovascular hospital spending
title_full A cost‐effectiveness threshold based on the marginal returns of cardiovascular hospital spending
title_fullStr A cost‐effectiveness threshold based on the marginal returns of cardiovascular hospital spending
title_full_unstemmed A cost‐effectiveness threshold based on the marginal returns of cardiovascular hospital spending
title_short A cost‐effectiveness threshold based on the marginal returns of cardiovascular hospital spending
title_sort cost‐effectiveness threshold based on the marginal returns of cardiovascular hospital spending
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585934/
https://www.ncbi.nlm.nih.gov/pubmed/30273967
http://dx.doi.org/10.1002/hec.3831
work_keys_str_mv AT vanbaalpieter acosteffectivenessthresholdbasedonthemarginalreturnsofcardiovascularhospitalspending
AT perryduxburymeg acosteffectivenessthresholdbasedonthemarginalreturnsofcardiovascularhospitalspending
AT bakxpieter acosteffectivenessthresholdbasedonthemarginalreturnsofcardiovascularhospitalspending
AT versteeghmatthijs acosteffectivenessthresholdbasedonthemarginalreturnsofcardiovascularhospitalspending
AT vandoorslaereddy acosteffectivenessthresholdbasedonthemarginalreturnsofcardiovascularhospitalspending
AT brouwerwerner acosteffectivenessthresholdbasedonthemarginalreturnsofcardiovascularhospitalspending
AT vanbaalpieter costeffectivenessthresholdbasedonthemarginalreturnsofcardiovascularhospitalspending
AT perryduxburymeg costeffectivenessthresholdbasedonthemarginalreturnsofcardiovascularhospitalspending
AT bakxpieter costeffectivenessthresholdbasedonthemarginalreturnsofcardiovascularhospitalspending
AT versteeghmatthijs costeffectivenessthresholdbasedonthemarginalreturnsofcardiovascularhospitalspending
AT vandoorslaereddy costeffectivenessthresholdbasedonthemarginalreturnsofcardiovascularhospitalspending
AT brouwerwerner costeffectivenessthresholdbasedonthemarginalreturnsofcardiovascularhospitalspending